AMAshok Morsu

Ashok Morsu

*This is an algorithmically generated author record based on publicly available information.

Ashok Morsu has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evaluation of Potential Antidepressant Activity of Laserpitium Latifolium Plant: In Silico Molecular Docking, ADMET And In Vivo Analysis

    by V. V. Rajesham, P. Kishore Kumar, V. Sai Kiranmai, P. Narendra, V. Uma Maheswara Rao, Ashok Morsu

    Background: Globally, depression affects over 300 million people and is a leading cause of disability, yet current synthetic antidepressants often come with significant side effects such as weight gain, sexual dysfunction, and insomnia or suffer from a slow onset of action. This has driven a search for safer, plant-derived alternatives that can modulate the monoaminergic system (serotonin, norepinephrine, and dopamine) or target the neuro-inflammatory pathways. Aim: This study aims to investigate the antidepressant potential of an Ethanolic Extract of Laserpitium latifolium L (EELL). Methods: The plant material was extracted by maceration using ethanol as solvent. The obtained EELL was analysed by Gas Chromatography – Mass Spectrometry (GC-MS) to identify the active phytoconstituents. The selected phytoconstituents were selected as ligands, and human monoamine oxidase A (2Z5Y) was selected as the protein. Docking studies were performed, and finally, the extraction was used to perform in vivo antidepressant activity by using the Forced Swim Test (FST) and Tail Suspension method. Results: 29 compounds were identified through GC-MS analysis and in silico docking studies performed for 8 compounds using Monoamine Oxidase A (MAO-A; PDB ID: 2Z5Y) protein. out of 8 compounds, Blebbistatin exhibited superior binding affinity (-10.2 kcal/mol) compared to the standard MAO-A inhibitor, Imipramine (-8.0 kcal/mol). In the in vivo antidepressant study, 24 male Wistar albino rats were randomly divided into four groups: Group I (Normal control), Group II (Standard Imipramine, 10mg/kg), and Groups III and IV (Treatment groups, 200 and 400mg/kg, respectively). No morbidity and mortality were observed up to the dose of 2000 mg/kg. The antidepressant results showed that the extract significantly reduced immobility time in both the Forced Swim Test (FST) and Tail Suspension Test (TST) at doses of 200 and 400 mg/kg. Conclusion: The above findings suggest that L. latifolium L. exhibits antidepressant properties, supported by both in-silico and in vivo evidence. Major Findings: Laserpitium latifolium L. (EELL) demonstrated significant antidepressant-like effects in animal models, with the compound Blebbistatin showing higher binding affinity for MAO-A than the standard antidepressant Imipramine. Additionally, the extract exhibited a high safety profile, with no toxicity, morbidity, or mortality in rats at doses up to 2000 mg/kg, and GC-MS analysis identified 29 distinct bioactive compounds.


  • Stability‐Indicating RP‐HPLC Method Development and Validation for the Quantification of Ketorolac Tromethamine‐Related Impurities in Tablets Solid Oral Dosage Forms

    by Prasanna Kumar Lankalapalli, Naveen Maddukuri, Ashok Morsu, Vijaykumar Chollety, Pranitha Sambu, Teja Kamireddy

    The present manuscript discusses the development and validation of a gradient reversed‐phase HPLC method for determining impurities in Ketorolac Tromethamine tablet dosage formulations. The analytes were separated using an Agilent Zorbax SB C8 column (250 × 4.6 mm, 5.0‐μm particle size). The mobile phase consisted of 0.05‐M ammonium phosphate buffer at pH 3.0 (mobile phase A) and a mixture of 40% methanol and 60% tetrahydrofuran (mobile phase B). The column temperature was maintained at 40°C, with a flow rate of 1.0 mL/min. UV detection was performed at 254 nm. The method demonstrated high specificity, with a linearity range of 0.201–6.445 μg/mL and achieving a correlation coefficient of > 0.999. The method exhibited high accuracy, exceeding 97%. The developed method was validated according to international ICH guidelines for specificity, linearity, precision, accuracy, and robustness. Stress studies indicated that Ketorolac Tromethamine tablets were sensitive to basic, photolytic, and oxidative stress conditions. The method was deemed suitable for quality control purposes, including impurity determination in Ketorolac Tromethamine tablets and stability‐indicating studies.